{"id":"https://openalex.org/W7225759466","doi":"https://doi.org/10.1681/asn.2026ag8e5fwk","title":"Dapagliflozin Improves Kidney Function in the Adenine-Induced Mouse Model of CKD","display_name":"Dapagliflozin Improves Kidney Function in the Adenine-Induced Mouse Model of CKD","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7225759466","doi":"https://doi.org/10.1681/asn.2026ag8e5fwk"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2026ag8e5fwk","doi":"https://doi.org/10.1681/asn.2026ag8e5fwk","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2026ag8e5fwk","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059135702","display_name":"Maria Katarina Ougaard","orcid":"https://orcid.org/0000-0003-0226-3405","observed_orcids":["https://orcid.org/0000-0003-0226-3405"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Maria Katarina Ougaard","raw_affiliation_strings":["Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051989421","display_name":"Louise Thisted","orcid":"https://orcid.org/0000-0002-7783-8122","observed_orcids":["https://orcid.org/0000-0002-7783-8122"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Louise Thisted","raw_affiliation_strings":["Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013159889","display_name":"Grzegorz Jerzy Maciag","orcid":"https://orcid.org/0000-0002-6493-8415","observed_orcids":["https://orcid.org/0000-0002-6493-8415"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Grzegorz Maciag","raw_affiliation_strings":["Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036027949","display_name":"Frederikke Emilie Sembach","orcid":"https://orcid.org/0000-0002-4609-1863","observed_orcids":["https://orcid.org/0000-0002-4609-1863"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Frederikke Emilie Sembach","raw_affiliation_strings":["Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026668369","display_name":"Stefan Tasler","orcid":"https://orcid.org/0000-0002-2718-8432","observed_orcids":["https://orcid.org/0000-0002-2718-8432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Tasler","raw_affiliation_strings":["Vivoryon Therapeutics, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vivoryon Therapeutics, Halle, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113705413","display_name":"Torsten Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Torsten Hoffmann","raw_affiliation_strings":["Vivoryon Therapeutics, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vivoryon Therapeutics, Halle, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027238188","display_name":"Antje Meyer","orcid":"https://orcid.org/0000-0003-1675-4512","observed_orcids":["https://orcid.org/0000-0003-1675-4512"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antje Meyer","raw_affiliation_strings":["Vivoryon Therapeutics, Halle, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vivoryon Therapeutics, Halle, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073727992","display_name":"Michael S\u00f8berg Christensen","orcid":"https://orcid.org/0000-0003-1693-058X","observed_orcids":["https://orcid.org/0000-0003-1693-058X"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Michael Christensen","raw_affiliation_strings":["Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra AS, H\u00f8rsholm, Capital Region of Denmark, Denmark;","institution_ids":["https://openalex.org/I4210113742"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"10S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.016300000250339508,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":1.0},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9639999866485596},{"id":"https://openalex.org/keywords/adenine-induced-nephropathy","display_name":"adenine-induced nephropathy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7749999761581421},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.8011000156402588},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7633000016212463},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6205000281333923},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5974000096321106},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4968000054359436},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4271000027656555},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4239000082015991},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36640000343322754},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.3424000144004822},{"id":"https://openalex.org/C2777693530","wikidata":"https://www.wikidata.org/wiki/Q6594689","display_name":"Benzhydryl compounds","level":4,"score":0.31540000438690186},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.3066999912261963},{"id":"https://openalex.org/C2776356786","wikidata":"https://www.wikidata.org/wiki/Q1048573","display_name":"Tubulopathy","level":3,"score":0.27869999408721924},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.26420000195503235}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.2026ag8e5fwk","doi":"https://doi.org/10.1681/asn.2026ag8e5fwk","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2026ag8e5fwk","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225699346","https://openalex.org/W4403831943","https://openalex.org/W4289340048","https://openalex.org/W4284880780","https://openalex.org/W3125331010","https://openalex.org/W7225735058","https://openalex.org/W7225744066","https://openalex.org/W4391406016","https://openalex.org/W2954270656","https://openalex.org/W7225738752"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-11T00:00:00"}